|
4/25/2013 5:13:06 PM
|
IGI Laboratories Posts Q1 Loss Per Share Of $0.01 Vs. Loss $0.02 Year Ago
|
|
4/25/2013 3:00:53 PM
|
|
|
4/4/2013 8:06:50 AM
|
IGI Labs Says Submits Second ANDA In 2013 To US FDA, Bringing It Total Number Of Submissions To Ten
|
|
3/20/2013 11:01:11 AM
|
|
|
3/5/2013 4:30:17 PM
|
IGI Laboratories Q4 Loss Per Share $0.03 Vs Loss $0.01 Last Year
|
|
3/5/2013 3:01:05 PM
|
|
|
2/4/2013 8:12:50 AM
|
IGI Labs To Buy Topical Pharmaceutical Product Econazole Nitrate Cream 1% From Prasco
|
|
1/28/2013 9:12:57 AM
|
IGI Labs Announces Ninth ANDA Submission
|
|
1/4/2013 11:50:33 PM
|
|
|
1/4/2013 8:01:56 AM
|
IGI Laboratories Completes Filing Of 2 Product Development ANDAs With FDA
|
|
12/19/2012 8:11:36 AM
|
IGI Laboratories Appoints Kenneth Miller As SVP Of R&D
|
|
11/13/2012 4:01:38 PM
|
IGI Laboratories Q3 Loss Per Share $0.04 Vs. Loss $0.01 Prior Year
|
|
11/5/2012 8:39:36 AM
|
IGI Las To Launch First IGI Label Topical Prescription Drug Products
|
|
8/13/2012 4:14:08 PM
|
IGI Laboratories Posts Q2 Loss/Share Narrows To $0.01 From $0.02 Last Year
|
|
8/13/2012 3:00:38 PM
|
|
|
7/30/2012 9:17:52 AM
|
|
|
7/30/2012 9:05:53 AM
|
IGI Laboratories Announces Appointment Of Jason Grenfell-Gardner As President And Chief Executive Officer
|
|
6/29/2012 4:45:14 PM
|
|
|
6/29/2012 4:14:06 PM
|
IGI Laboratories Announces The Submission Of Two More ANDAs
|
|
6/5/2012 8:25:25 AM
|
|